Vanguard Group’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.96M | Sell |
|
|||||
|
2025
Q1 | $7.25M | Sell |
|
|||||
|
2024
Q4 | $10.7M | Sell |
|
|||||
|
2024
Q3 | $18.9M | Sell |
|
|||||
|
2024
Q2 | $31.2M | Buy |
|
|||||
|
2024
Q1 | $40.6M | Buy |
|
|||||
|
2023
Q4 | $35.9M | Buy |
|
|||||
|
2023
Q3 | $37.7M | Buy |
|
|||||
|
2023
Q2 | $48.9M | Buy |
|
|||||
|
2023
Q1 | $10.9M | Buy |
|
|||||
|
2022
Q4 | $16.2M | Buy |
|